. Author manuscript; available in PMC: 2007 Nov 27.

Published in final edited form as: Cancer Detect Prev. 2007;31(4):310–315. doi: 10.1016/j.cdp.2007.07.005

Table 3.

Genotype frequencies and risk of prostate cancer.

UGT2B17 genotype^a	Cases (%)	Controls (%)	OR (95% CI)^b
(+/+)	201 (49)	190 (48)	1.00 (Ref.)
(+/0)	168 (41)	159 (40)	0.99 (0.73–1.35)
(0/0)	42 (10)	48 (12)	0.89 (0.55–1.45)
(+/+)	201 (49)	190 (48)	1.00 (Ref.)
(+/0) + (0/0)	210 (51)	207 (52)	0.97 (0.73–1.30)
(+/+) + (+/0)	369 (90)	349 (88)	1.00 (Ref.)
(0/0)	42 (10)	48 (12)	0.89 (0.56–1.43)

The three genotypes of the UGT2B17 deletion polymorphism are shown as: (+/+), two alleles of the UGT2B17 gene; (+/0), one allele of the UGT2B17 gene and one gene deletion allele; (0/0), UGT2B17 null, two copies of the deletion allele.

Adjusted for age, smoking pack-years, and family history of prostate cancer.